2023-07-21 14:04:00
The investigation of the FDI Clinical Research is aimed at patients suffering from this condition in Puerto Rico.
By: Luisa Ochoa
Julio 21, 2023
FDI Clinical Research announced that it is recruiting patients with cirrhosis decompensated to participate in the clinical study of an innovative treatment that seeks to combat the damage caused by this condition.
“At FDI Clinical Research, we are committed to developing treatments that improve the quality of life for those with cirrhosis unbalanced. Our team of researchers is conducting clinical studies that seek to develop therapies that can reverse some of the damage caused by this condition, until now considered irreversible,” explained Dr. José Rodríguez Orengo, CEO of FDI Clinical Research.
For her part, Dr. Vivian Tamayo, researcher in the study, highlighted the importance of recruiting patients with cirrhosis decompensated to advance in the knowledge and treatment of this disease.
“This study represents a unique opportunity to contribute to the advancement of science in the management of cirrhosis unbalanced. We are looking for courageous and committed individuals who want to be involved in finding innovative solutions for this condition,” she stated.
The cirrhosis Decompensated is a chronic and irreversible liver disease that can have serious consequences for the health. Among the complications that may arise are coagulation problems, excessive accumulation of fluid in the abdomen (ascites), bleeding from esophageal varices, and hepatic encephalopathy.
“If you are a person who suffers from cirrhosis unbalanced, we invite you to consider this valuable opportunity to contribute to medical science and potentially improve your quality of life. At FDI Clinical Research, we strive to provide a safe environment for our patients, and we guarantee confidentiality and ethics in all of our research,” said Dr. Tamayo.
People interested in participating in the study should contact FDI Clinical Research at (787) 722-1248.
1689959765
#Clinical #study #offers #innovative #treatment #opportunity #patients #decompensated #cirrhosis
